Ideally, our nation's pharmaceutical supply chain should provide medicines and medical supplies of the highest quality, in the right quantity, to the right customer at the right place. Supplies should arrive at the right time, and at a fair cost that is aligned with broader public health improvement goals for individuals and communities. Panelists will explore the dynamics of the pharmaceutical supply chain in the US from the public health perspective, drawing on lessons learned from the COVID-19 pandemic. Subject matter experts will discuss upstream and downstream aspects of today's supply chain, and envision the future of the pharmaceutical supply chain to realize optimal efficiency, delivery, and resilience across the US health-care ecosystem while advancing public health. 

Moderator

Sarah Owermohle

Washington Correspondent, STAT

Speakers

Tom Cotter

Executive Director, Healthcare Ready

Chip Davis

President and CEO, Healthcare Distribution Alliance

Mark McClellan

Director, Duke-Margolis Center for Health Policy, Duke University

Gary Puckrein

President and CEO, National Minority Quality Forum